Поиск

 


Поиск оптимального соотношения эффективности и безопасности при антитромбоцитарной терапии ишемической болезни сердца

... acid remains the basis of anti-platelet therapy for stable ischemic heart disease (IHD), including conditino after coronary artery bypass grafting. Double anti-platelet therapy (APT) consisting of acetylsalicylic acid and a P2Y12 receptor inhibitor (clopidogrel, prasugrel, ticagrelor) reduces the risk of recurrence of major ischemic complications in patients with acute coronary syndromes (ACS) and/or those who underwent percutaneous coronary intervention (PCI), but inevitably increases the risk of ...

Изменен: 13.06.2018
Путь: Главная / Врачам / Кардиология

Отсортировано по релевантности | Сортировать по дате